Northwestern Medicine investigators have discovered that uterine serous carcinoma (USC) tumors in Black patients express more aggressive and immunosuppressive features than tumors in white patients, according to a new study ...
14 hours ago
0
11
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers. The preclinical study, ...
Jul 29, 2024
0
0
Ovarian cancer, often diagnosed at an advanced stage, presents significant treatment challenges because patients tend to develop resistance to conventional therapies quickly. Despite aggressive treatment, recurrence rates ...
Jun 26, 2024
0
0
Cleveland Clinic researchers have discovered a new location for a protein that helps ovarian cancer cells resist chemotherapy treatments and that fosters aggressive cancer stem cell growth.
Jun 10, 2024
0
47
A multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor immune responses in otherwise difficult to treat ...
Apr 30, 2024
0
0
When Kate Middleton, the princess of Wales, announced in March 2024 that she was receiving "preventive chemotherapy" following abdominal surgery, many wondered what that entails. Formally known as adjuvant therapy, administering ...
Mar 27, 2024
0
12
In ovarian cancer, the abnormal expression of various metabolic enzymes in the metabolism of polyunsaturated fatty acids (PUFA) is involved in the development of tumors and immune regulation. Most ovarian cancer patients ...
Mar 14, 2024
0
0
Newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Feb 27, 2024
0
37
CureLab Oncology, a clinical-stage, pre-IPO biotech company, announced that its novel biological agent, Elenagen, has been shown to significantly enhance standard chemotherapy and provides clinical benefits for the patients ...
Feb 22, 2024
0
0
A model based on artificial intelligence is able to predict the therapy outcome (measured by volumetric reduction of tumor lesions) in 80% of ovarian cancer patients. The AI-based model has an accuracy of 80%, significantly ...
Nov 13, 2023
0
17
